Galectin Therapeutics Inc. Soared
Tue, Jun 17, 2025 at 07:10 PM
Galectin Therapeutics Inc. (GALT:NASDAQ) jumped higher at $2.39, a gain of 60.4%. On Tue, Jun 17, 2025, GALT:NASDAQ hit a New 2-Week High of $2.39. The stock got featured on our News Catalysts scanner on Tue, Jun 10, 2025 at 11:17 AM in the 'BIOTECH' category. From Tue, Jun 03, 2025, the stock recorded 70.00% Up Days and 45.45% Green Days
About Galectin Therapeutics Inc. (GALT:NASDAQ)
Galectin Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in drug research and development to create new therapies for fibrotic disease and cancer.
Top 10 Gainers:
- CERo Therapeutics Holdings, Inc. (CERO:NASDAQ), 188.73%
- Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 167.24%
- Eyenovia, Inc. (EYEN:NASDAQ), 134.68%
- Robin Energy Ltd. (RBNE:NASDAQ), 91.85%
- Houston American Energy Corp. (HUSA:NYSEMKT), 88.68%
- Verve Therapeutics, Inc. (VERV:NASDAQ), 81.5%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 66.53%
- Galectin Therapeutics Inc. (GALT:NASDAQ), 60.4%
- Beyond Air, Inc. (XAIR:NASDAQ), 58.69%
- Digital Turbine, Inc. (APPS:NASDAQ), 56.76%